interleukin alleviates metabolic disorders restores mucosal immunity diabetes
connection altered gut microbiota metabolic disorders obesity diabetes cardiovascular disease well established defects preserving integrity mucosal barriers can result systemic endotoxaemia contributes chronic low-grade inflammation promotes development ofmetabolic syndrome- interleukin il exerts essential roles eliciting antimicrobial immunity maintaining mucosal barrier integrity within intestine investigate connection il metabolic disorders find induction il innate lymphoid cells cd4+ t cells impaired obese mice various immune challenges especially colon infection citrobacter rodentium innate lymphoid cell populations largely intact obese mice upregulation il- cytokine upstream il- compromised infection consequently mice susceptible c rodentium infection exogenous il il able restore mucosal host defence importantly unveil unexpected functions il regulating metabolism mice deficient il receptor fed high-fat diet prone developing metabolic disorders strikingly administration exogenous il genetically obese leptin-receptor-deficient db/db mice mice fed high-fat diet reverses many metabolic symptoms including hyperglycaemia insulin resistance il shows diverse metabolic benefits improves insulin sensitivity preserves gut mucosal barrier endocrine functions decreases endotoxaemia chronic inflammation regulates lipid metabolism liver adipose tissues summary identify il pathway novel target therapeutic intervention metabolic diseases
